// Company Overview //
| Stock Name | 金活醫藥集團有限公司 |
|---|
| Stock Code | 01110 |
|---|
| Company Full Name | 金活醫藥集團有限公司 |
|---|
| Industry | 醫療保健 |
|---|
| Principal Activities | 主要於中國及香港從事品牌進口醫藥及保健產品的分銷，以及制造和銷售電療、物療設備及一般醫療檢查設備。 |
|---|
| Listing Date | 2010-11-25 |
|---|
| Listing Rules Era | Old Rules |
|---|
| Listing Rules Chapter | No data |
|---|
| Weighted Voting Rights (WVR) | No |
|---|
| Registered Address (Mainland China) | 中國廣東省深圳市南山區大新路198號馬家龍創新大廈A座8-9樓 |
|---|
| Business Address (Hong Kong) | No data |
|---|
| Place of Incorporation | No data |
|---|
| Listing Method | No data |
|---|
| Listing Board | Main Board |
|---|
| Website | http://www.kingworld.com.cn |
|---|
| Share Registrar | 卓佳證券登記有限公司 |
|---|
| Registrar Contact | (852)2980 1333 |
|---|
| A-Share/US Dual Listing | No data |
|---|
// Offering Information //
| Prospectus Date | 2010-11-12 |
|---|
| Offer Price | HK$ 1.60 / shares |
|---|
| Total Funds Raised | HK$ 120,000,000 |
|---|
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
|---|
// First Day Performance
| First Day Close | Loading... |
|---|
| First Day Open | HK$ 2.01 |
|---|
| First Day Change | 28.13% |
|---|
| First Day Volume | 162517000.0 |
|---|
| First Day Turnover | 330273000.0 |
|---|
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、約60%或130.02百萬港元，將用作收購最多三項分銷業務；
2、約20%或43.34百萬港元，將用作通過于深圳建立其自有配備標準GSP資格的配送中心第一階段以提升其向客戶運送貨物的服務；
3、約10%或21.67百萬港元，將用作增加約3,000產品專柜；
4、約10%或21.67百萬港元，將用作本集團的額外一般營運資金。 |
|---|
// Underwriting Syndicate //
联席账簿管理人 (1)
国泰君安证券（香港）有限公司
联席牵头经办人 (1)
国泰君安证券（香港）有限公司
// Cornerstone Investors //
This stock has no cornerstone investors.
// Directors & Management //
| Chairman | 趙利生 |
|---|
| Company Secretary | 陳漢云 |
|---|
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 趙利生及家族成員(65.88%)；Sinopharm Healthcare Fund L.P.(9.99%) |
|---|
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.
